Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Rises By 89.1%

Biomerica, Inc. (NASDAQ:BMRA) was the target of a significant increase in short interest during the month of September. As of September 15th, there was short interest totaling 219,400 shares, an increase of 89.1% from the August 31st total of 116,000 shares. Currently, 8.5% of the shares of the stock are sold short. Based on an average trading volume of 797,900 shares, the days-to-cover ratio is currently 0.3 days. Based on an average trading volume of 797,900 shares, the days-to-cover ratio is currently 0.3 days. Currently, 8.5% of the shares of the stock are sold short.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Biomerica in a research note on Saturday, September 27th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, Biomerica has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Biomerica stock. Bulltick Wealth Management LLC acquired a new stake in shares of Biomerica, Inc. (NASDAQ:BMRA) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 137,149 shares of the company’s stock, valued at approximately $78,000. Bulltick Wealth Management LLC owned about 5.39% of Biomerica at the end of the most recent quarter. 22.28% of the stock is currently owned by institutional investors.

Biomerica Trading Up 1.4%

Shares of NASDAQ:BMRA opened at $2.80 on Friday. The stock’s 50-day moving average price is $3.06 and its 200-day moving average price is $3.46. Biomerica has a 12-month low of $2.08 and a 12-month high of $10.16. The stock has a market capitalization of $8.04 million, a P/E ratio of -1.21 and a beta of 0.34.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.